242PD - Initial results of a phase 1 dose expansion cohort of M6620 (formerly VX-970), an ATR inhibitor, in combination with cisplatin in patients with advanced triple-negative breast cancer NCT02157792)
| Autor: | Telli, M.L., Lord, S., Dean, E., Abramson, V., Arkenau, H-T., Becerra, C., Tolaney, S.M., Tang, R., Penney, M.S., Pollard, J., Conboy, G., Fields, S.Z., Shapiro, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v76-v76 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|